Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: Current status and review
- PMID: 36129158
- DOI: 10.1111/aor.14396
Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: Current status and review
Abstract
Background: Chronic kidney disease (CKD) is a major cause of early death worldwide. By 2030, 14.5 million people will have end-stage kidney disease (ESKD, or CKD stage 5), yet only 5.4 million will receive kidney replacement therapy (KRT) due to economic, social, and political factors. Even for those who are offered KRT by various means of dialysis, the life expectancy remains far too low.
Observation: Researchers from different fields of artificial organs collaborate to overcome the challenges of creating products such as Wearable and/or Implantable Artificial Kidneys capable of providing long-term effective physiologic kidney functions such as removal of uremic toxins, electrolyte homeostasis, and fluid regulation. A focus should be to develop easily accessible, safe, and inexpensive KRT options that enable a good quality of life and will also be available for patients in less-developed regions of the world.
Conclusions: Hence, it is required to discuss some of the limits and burdens of transplantation and different techniques of dialysis, including those performed at home. Furthermore, hurdles must be considered and overcome to develop wearable and implantable artificial kidney devices that can help to improve the quality of life and life expectancy of patients with CKD.
Keywords: chronic kidney disease; kidney replacement therapies; wearable and implantable artificial kidneys.
© 2022 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Similar articles
-
Innovations in Wearable and Implantable Artificial Kidneys.Am J Kidney Dis. 2018 Nov;72(5):745-751. doi: 10.1053/j.ajkd.2018.06.005. Epub 2018 Aug 23. Am J Kidney Dis. 2018. PMID: 30146422 Review.
-
Ambulatory Hemodialysis-Technology Landscape and Potential for Patient-Centered Treatment.Clin J Am Soc Nephrol. 2020 Jan 7;15(1):152-159. doi: 10.2215/CJN.01970219. Epub 2019 Nov 14. Clin J Am Soc Nephrol. 2020. PMID: 31727617 Free PMC article. Review.
-
Creating a wearable artificial kidney: where are we now?Expert Rev Med Devices. 2015 Jul;12(4):373-6. doi: 10.1586/17434440.2015.1053466. Expert Rev Med Devices. 2015. PMID: 26076370
-
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges.Nat Rev Nephrol. 2023 Aug;19(8):481-490. doi: 10.1038/s41581-023-00726-9. Epub 2023 Jun 5. Nat Rev Nephrol. 2023. PMID: 37277461 Free PMC article. Review.
-
How can we advance in renal replacement therapy techniques?Nefrologia (Engl Ed). 2019 Jul-Aug;39(4):372-378. doi: 10.1016/j.nefro.2018.08.012. Epub 2019 Mar 4. Nefrologia (Engl Ed). 2019. PMID: 30846291 Review. English, Spanish.
Cited by
-
Hydrogel-Based Vascularized Organ Tissue Engineering: A Systematized Review on Abdominal Organs.Gels. 2024 Oct 12;10(10):653. doi: 10.3390/gels10100653. Gels. 2024. PMID: 39451306 Free PMC article. Review.
-
Transportable, portable, wearable and (partially) implantable haemodialysis systems: comparison of technologies and readiness levels.Clin Kidney J. 2024 Aug 24;17(9):sfae259. doi: 10.1093/ckj/sfae259. eCollection 2024 Sep. Clin Kidney J. 2024. PMID: 39301271 Free PMC article. Review.
-
Artificial kidney: Challenges and opportunities.World J Transplant. 2024 Mar 18;14(1):89025. doi: 10.5500/wjt.v14.i1.89025. World J Transplant. 2024. PMID: 38576754 Free PMC article. Review.
-
Numerical Simulation of Mass Transfer in Hollow Fiber Membrane Module for Membrane-Based Artificial Organs.Membranes (Basel). 2024 Mar 10;14(3):67. doi: 10.3390/membranes14030067. Membranes (Basel). 2024. PMID: 38535286 Free PMC article.
-
Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic Dialysis.Int J Nephrol Renovasc Dis. 2024 Mar 20;17:91-104. doi: 10.2147/IJNRD.S387598. eCollection 2024. Int J Nephrol Renovasc Dis. 2024. PMID: 38525412 Free PMC article. Review.
References
REFERENCES
-
- Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. The lancet. 2017;389(10075):1238-52.
-
- Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380-3.
-
- The United States Renal Data System. 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2021.
-
- Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-422D.
-
- Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials